Stocktoria
Allarity Therapeutics, Inc. ALLR
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-12-21
Allarity Therapeutics, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -3939.1% | — | — | — | — |
| Net margin | -3509.7% | — | — | — | — |
| FCF margin | -4633.8% | — | — | — | — |
| Return on assets | -61.5% | -108.2% | -100.3% | -110.4% | -53.7% |
| Return on equity | -114.3% | -207.6% | 432.6% | 14210.6% | -146.8% |
| Debt / equity | — | — | -0.98× | -23.40× | — |
| Current ratio | 2.13 | 2.06 | 0.14 | 0.44 | 1.03 |
Source: SEC EDGAR filings · CIK 0001860657 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.